Open AccessJournal Article
Long-term survival.
Cho Yw,Terasaki Pi +1 more
TLDR
In transplants performed between 1971 and 1986, first cadaver donor grafts had a half-life ranging from 6.6 to 7.5 years in the period after the first year, and for patients receiving kidneys with no HLA-A,B mismatches, the average half- life was 10.1 years.Abstract:
1. In transplants performed between 1971 and 1986, first cadaver donor grafts had a half-life ranging from 6.6 to 7.5 years in the period after the first year. Second cadaver donor grafts had a half-life of 5.1 to 6.5 years. Parental donor grafts had a half-life of 9.3 to 11.8 years, whereas HLA identical sibling donor transplants had a half-life of 19.1 to 26.5 years. Siblings with no haplotype in common had an average half-life of 8.7 years. 2. Between 1971 and 1984, white recipients had an average half-life of 7.7 years, which increased to 9.3 years in 1985-1986. Black recipients' half-life decreased from 5.4 years in 1975-1976 to 3.5 years in 1985-1986. The reason for this decrease is not apparent. 3. The half-life of transplants of different recipient ages did not vary significantly. The average half-life during this period of study was 7.4 years for those younger than 21 years of age, 8.2 years for recipients 21 to 50 and 6.7 years for those older than 50. 4. In the early data, there was some evidence that the half-life of kidneys with cold ischemia below 13 hours was superior. However, in the latest period (between 1983 and 1986) the average half-life was 7.6 years for CIT below 13 hours, 7.2 years for those with 13 to 24 hours and 6.4 years for more than 24 hours. 5. For patients receiving kidneys with no HLA-A,B mismatches, the average half-life was 10.1 years. Those with A,B mismatches had a half-life of 6.7 years, and for those with no A,B antigens in common, the average half-life was 6 years. 6. In the period after 1981, the average half-life of patients with no A,B,DR mismatches was 9.1 years compared with 6.5 years for those with A,B,DR mismatches and 5.4 years for those with no A,B,DR antigens in common.read more
Citations
More filters
Journal ArticleDOI
Fatally flawed? A review and ethical analysis of lethal congenital malformations.
TL;DR: This review and ethical analysis of lethal congenital malformations in mice found that the current standard of care for these conditions is fatally flawed.
Journal ArticleDOI
Infections in the spinal cord-injured population: a systematic review.
L Y Garcia-Arguello,John C. O’Horo,Ann M. Farrell,R Blakney,R Blakney,Muhammad R. Sohail,Charlesnika T. Evans,Charlesnika T. Evans,Nasia Safdar,Nasia Safdar +9 more
TL;DR: There is a paucity of literature on consistently effective infection prevention strategies in SCI patients, and identification and implementation of evidence-based interventions that optimize prevention and management of infections in this patient population are needed.
Journal ArticleDOI
Children's and Adults' Spontaneous False Memories: Long-Term Persistence and Mere-Testing Effects
TL;DR: Important new findings were that the persistence effect and the false-memory creation effect were greatest for statements that would be regarded as factually incorrect reports of events in sworn testimony and that, like suggestive questioning, interviews that involve nonsuggestive recognition questions may nevertheless taint children's memories.
Journal ArticleDOI
The CD28-B7 costimulatory pathway and its role in autoimmune disease
TL;DR: It is interesting that blockade of B7 molecules, which disrupts interactions with CD28 and prevents delivery of the CD28 costimulus, also alters the immune responses to self antigens and prevents the development of clinical disease in murine models of systemic and organ‐specific autoimunity.
Journal ArticleDOI
Distinct efficacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of parkinson’s disease
Xuan Wang,Yanyan Lu,Huanqing Zhang,Kun Wang,Qi-Hua He,Yue Wang,Xian-Yu Liu,Linsong Li,Xiaomin Wang +8 more
TL;DR: It is found that a combination of 50 ng/ml fibroblast growth factor 8, 10 ng/ ml glial cell line‐derived neurotrophic factor and 10 μM forskolin facilitated the differentiation of human fetal mesencephalic progenitor cells into dopaminergic neurons in vitro.